drugset

drugset / Trial / NCT00191594

Open-Label Duloxetine Extension Phase in Patients Who Have Completed Previous Duloxetine Trials

NCT00191594 ↗

Phase 3 Completed 105 enrolled Eli Lilly and Company

Non-randomizedSingle-groupOpen-labelTreatment

Summary

A study in patients with depression

Timeline

Start: 2005-03
Primary completion: —
Completion: 2006-08

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Duloxetine	Small molecule	—	—

Indications